Kidney Failure Risk Equation (KFRE) Calculator – 2-Year and 5-Year CKD Risk

Clinical calculation support · Verify results before clinical use

Patient information

Enter the patient's clinical and laboratory values to estimate 2-year and 5-year kidney failure risk.

Adult patients; enter age in completed years.

The equation uses a male/female model variable.

KFRE is intended for CKD G3–G5 (eGFR below 60 mL/min/1.73 m²).

ACR must be greater than zero because the equation uses its natural logarithm.

The calculator converts ACR to mg/mmol internally (1 mg/mmol ≈ 8.84 mg/g).

About the Kidney Failure Risk Equation

The 4-variable Kidney Failure Risk Equation (KFRE) estimates the probability of kidney failure requiring dialysis or kidney transplantation at 2 and 5 years in adults with CKD. It uses age, sex, estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio (ACR).

Model and calibration used

This calculator implements the 4-variable KFRE with the non-North American regional recalibration reported by Tangri and colleagues in the 2016 multinational validation study. The linear predictor is:

LP = −0.2201 × (age/10 − 7.036) + 0.2467 × (male − 0.5642) − 0.5567 × (eGFR/5 − 7.222) + 0.4510 × (ln[ACR in mg/mmol] − 5.137).
Risk(t) = 1 − S₀(t)exp(LP)
Non-North American baseline survival: S₀(2 years) = 0.9832; S₀(5 years) = 0.9365. Male = 1; female = 0.

Clinical use and KDIGO 2024 practice points

  • In CKD G3–G5, KDIGO recommends using an externally validated risk equation to estimate absolute kidney failure risk.
  • A 5-year kidney failure risk of 3%–5% may help determine the need for nephrology referral, alongside eGFR, ACR, and other clinical considerations.
  • A 2-year risk greater than 10% may help determine timing of multidisciplinary care.
  • A 2-year risk greater than 40% may help guide kidney replacement therapy modality education and preparation, including access planning or transplant referral.

Scope and limitations

  • Use in adults with CKD G3–G5 (eGFR below 60 mL/min/1.73 m²); risk equations developed for G3–G5 may not be valid in CKD G1–G2.
  • The predicted outcome is kidney failure treated with dialysis or transplantation; it is not a prediction of mortality, cardiovascular events, or all CKD progression.
  • Regional recalibration improves calibration in many non-North American cohorts, but does not establish Indonesia-specific calibration. Interpret results with local clinical context.
  • Do not apply to patients already receiving dialysis or with a functioning kidney transplant.

References

Tangri N, Stevens LA, Griffith J, et al. A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure. JAMA. 2011;305(15):1553–1559. Original development and validation study. DOI: 10.1001/jama.2011.451.
Tangri N, Grams ME, Levey AS, et al; CKD Prognosis Consortium. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016;315(2):164–174. External validation and regional recalibration. DOI: 10.1001/jama.2015.18202.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105(4S):S117–S314. Recommendation 2.2.1 and Practice Points 2.2.1–2.2.4. Official guideline: KDIGO CKD Evaluation and Management.
Clinical disclaimer: This calculator is an educational and clinical decision-support aid, not a substitute for individualized assessment. Confirm input units and laboratory results. Interpret predicted risk alongside CKD cause, trajectory of eGFR and albuminuria, comorbidities, competing risks, patient preferences, and local referral pathways. KDIGO thresholds are practice points to support—not dictate—clinical decisions.